Pharmatest Services will be attending the 31st Annual Congress of the World Muscle Society (WMS 2026) in Hiroshima, Japan, from 29 September to 3 October 2026.

The congress brings together leading experts from academia, biotechnology, pharmaceutical companies, and clinical research to discuss the latest developments in neuromuscular and musculoskeletal diseases. The event provides an excellent opportunity to explore new scientific insights, emerging therapeutic approaches, and future directions in translational research.

Representing Pharmatest at WMS 2026 will be Dr. Jukka Rissanen, CEO, and Dr. Katja Fagerlund, Research Director.

We look forward to participating in scientific discussions and reconnecting with colleagues, collaborators, and members of the global musculoskeletal research community.

If you will be attending WMS 2026, we would be pleased to meet and exchange perspectives on current developments in musculoskeletal research and drug development.

Event: 31st Annual Congress of the World Muscle Society (WMS 2026)
Location: Hiroshima, Japan
Date: 29 September – 3 October 2026
Attendees: Dr. Jukka Rissanen, CEO, and Dr. Katja Fagerlund, Research Director

For meeting requests, please contact us at info@pharmatest.com.